Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
Kawai T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M. Kawai T, et al. Among authors: iwasaki y. Am J Cardiol. 2015 Jun 1;115(11):1549-54. doi: 10.1016/j.amjcard.2015.02.058. Epub 2015 Mar 12. Am J Cardiol. 2015. PMID: 25851796
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M. Tamaki S, et al. Among authors: iwasaki y. J Am Coll Cardiol. 2009 Feb 3;53(5):426-35. doi: 10.1016/j.jacc.2008.10.025. J Am Coll Cardiol. 2009. PMID: 19179201 Free article.
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, Tanaka K, Iwasaki Y, Yasui T, Ueda H, Okada T, Kawasaki M, Levy WC, Komuro I, Fukunami M. Kuramoto Y, et al. Among authors: iwasaki y. Am J Cardiol. 2011 Apr 15;107(8):1185-90. doi: 10.1016/j.amjcard.2010.12.019. Epub 2011 Feb 23. Am J Cardiol. 2011. PMID: 21349482
Early repolarization pattern associated with sudden cardiac death: long-term follow-up in patients with chronic heart failure.
Furukawa Y, Yamada T, Morita T, Iwasaki Y, Kawasaki M, Kikuchi A, Naito T, Fujimoto T, Ozu K, Kondo T, Sengoku K, Yamamoto H, Masuyama T, Fukunami M. Furukawa Y, et al. Among authors: iwasaki y. J Cardiovasc Electrophysiol. 2013 Jun;24(6):632-9. doi: 10.1111/jce.12093. Epub 2013 Feb 11. J Cardiovasc Electrophysiol. 2013. PMID: 23397903
Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure.
Hakui H, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Ishimi M, Sato Y, Seo M, Ozaki T, Ikeda I, Fukuhara E, Sakata Y, Fukunami M. Hakui H, et al. Among authors: iwasaki y. Am J Cardiol. 2016 Jun 15;117(12):1947-52. doi: 10.1016/j.amjcard.2016.03.047. Epub 2016 Apr 6. Am J Cardiol. 2016. PMID: 27237625
The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores.
Kondo T, Yamada T, Morita T, Furukawa Y, Tamaki S, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M. Kondo T, et al. Among authors: iwasaki y. Heart Vessels. 2017 Feb;32(2):193-200. doi: 10.1007/s00380-016-0861-7. Epub 2016 Jun 21. Heart Vessels. 2017. PMID: 27325225
Risk stratification of patients with chronic heart failure using cardiac iodine-123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction.
Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Kawai T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M. Tamaki S, et al. Among authors: iwasaki y. ESC Heart Fail. 2015 Dec;2(4):116-121. doi: 10.1002/ehf2.12057. Epub 2015 Aug 17. ESC Heart Fail. 2015. PMID: 27708857 Free PMC article.
Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction　- Prospective Randomized Controlled Study.
Tamaki S, Sato Y, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Ozaki T, Seo M, Ikeda I, Fukuhara E, Abe M, Nakamura J, Fukunami M. Tamaki S, et al. Among authors: iwasaki y. Circ J. 2017 Apr 25;81(5):740-747. doi: 10.1253/circj.CJ-16-1122. Epub 2017 Feb 16. Circ J. 2017. PMID: 28202885 Free article. Clinical Trial.
Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.
Yamamoto H, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Ozaki T, Seo M, Sato Y, Ikeda I, Fukuhara E, Abe M, Nakamura J, Fukunami M. Yamamoto H, et al. Among authors: iwasaki y. J Nucl Cardiol. 2019 Feb;26(1):109-117. doi: 10.1007/s12350-017-0913-0. Epub 2017 May 12. J Nucl Cardiol. 2019. PMID: 28500540
3,489 results